INTERNATIONAL PATENT: SPARK THERAPEUTICS, INC. FILES APPLICATION FOR "INHIBITORY NUCLEIC ACID TARGETING ALPHA SYNUCLEIN EXPRESSION"

GENEVA, April 30 -- SPARK THERAPEUTICS, INC. (3737 Market Street, Suite 1300Philadelphia, PA 19104) filed a patent application (PCT/US2024/051907) for "INHIBITORY NUCLEIC ACID TARGETING ALPHA SYNUCLEIN EXPRESSION" on Oct 18, 2024. With publication no. WO/2025/085713, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GONZALEZ-ALEGRE, Pedro (c/o Spark Therapeutics, Inc.3737 Market Street, Suite 1300Philadelphia, PA 19104), BASU, Sambuddha (c/o Spark Therapeutics, Inc.3737 Market Street, Suite 1300Philadelphia, PA 19104), BIFE...